These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4027505)

  • 1. Allopurinol treatment of renal calcium stone disease.
    Fellström B; Backman U; Danielson BG; Holmgren K; Johansson G; Lindsjö M; Ljunghall S; Wikström B
    Br J Urol; 1985 Aug; 57(4):375-9. PubMed ID: 4027505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder.
    Coe FL
    Ann Intern Med; 1977 Oct; 87(4):404-10. PubMed ID: 907239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients.
    Strauss AL; Coe FL; Parks JH
    Arch Intern Med; 1982 Mar; 142(3):504-7. PubMed ID: 7065787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine composition in patients with renal stone disease during treatment with allopurinol.
    Tiselius HG; Larsson L
    Scand J Urol Nephrol; 1980; 14(1):65-71. PubMed ID: 7375845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the discriminant index in dynamic treatment to reduce recurrence of calcium oxalate kidney stones.
    Perlberg S; Azoury R; Garti N; Sarig S
    Br J Urol; 1985 Oct; 57(5):500-4. PubMed ID: 2998532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():265-71. PubMed ID: 6938003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-uric acid nephrolithiasis.
    Coe FL
    Arch Intern Med; 1978 Jul; 138(7):1090-3. PubMed ID: 666467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in inhibitory potential in urine of hyperuricosuric calcium oxalate stone formers effected by allopurinol and orthophosphates.
    Goldwasser B; Sarig S; Azoury R; Wax Y; Hirsch D; Perlberg S; Many M
    J Urol; 1984 Nov; 132(5):1008-11. PubMed ID: 6492268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium lithiasis: uric acid under question].
    Petit C
    Nephrologie; 1984; 5(5):192-4. PubMed ID: 6531055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of allopurinol in the prevention of calcium oxalate calculi.
    Ettinger B; Tang A; Citron JT; Livermore B; Williams T
    N Engl J Med; 1986 Nov; 315(22):1386-9. PubMed ID: 3534570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopurinol treatment of uric-acid disorders in calcium-stone formers.
    Coe FL; Raisen L
    Lancet; 1973 Jan; 1(7795):129-31. PubMed ID: 4118468
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences.
    Borghi L; Meschi T; Guerra A; Novarini A
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S78-86. PubMed ID: 7508066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis.
    Coe FL; Kavalach AG
    N Engl J Med; 1974 Dec; 291(25):1344-50. PubMed ID: 4610395
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol].
    Okada Y; Nonomura M; Takeuchi H; Kawamura J; Yoshida O
    Hinyokika Kiyo; 1986 Sep; 32(9):1247-57. PubMed ID: 3812144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical treatment of idiopathic calcium nephrolithiasis.
    Surian M; Malberti F; Colussi G; De Ferrari ME; Rombolà G; Benazzi E; Minetti L
    Contrib Nephrol; 1987; 58():172-5. PubMed ID: 3691120
    [No Abstract]   [Full Text] [Related]  

  • 16. Allopurinol and thiazide effects on new urinary stone formed after discontinued therapy in patients with urinary stones.
    Kohri K; Kodama M; Katayama Y; Ishikawa Y; Takada M; Kataoka K; Katoh Y; Iguchi M; Kurita T
    Urology; 1990 Oct; 36(4):309-14. PubMed ID: 2219608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the stone former.
    Burns JR; Finlayson B
    Semin Urol; 1984 Feb; 2(1):34-44. PubMed ID: 6463460
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigation and treatment of renal calculi.
    Evans RA; Maher PO; Agostino M; Wong SY; Marel GM; Hills E
    Med J Aust; 1985 Sep; 143(7):278-81. PubMed ID: 4046915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of allopurinol treatment on the prevention of hyperuricosuric calcium oxalate lithiasis.
    Hofbauer J; Zechner O
    Eur Urol; 1988; 15(3-4):227-9. PubMed ID: 3215256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preventive medical treatment of recurrent urinary calcium calculi].
    François B; Trolliet P; Cahen R; Semet MP
    Nephrologie; 1986; 7(1):9-12. PubMed ID: 3960261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.